Cas:3068-76-6 N-(3-(Trimethoxysilyl)propyl)aniline manufacturer & supplier

Chemical Name:N-(3-(Trimethoxysilyl)propyl)aniline

CAS.NO:3068-76-6

Synonyms:N-[3-(Trimethoxysilyl)propyl]aniline;N-Phenylaminopropyltrimethoxysilane;MFCD00053673;Benzenamine, N-[3-(trimethoxysilyl)propyl]-;Benzenamine, N-(3-(trimethoxysilyl)propyl)-;n-(3-(trimethoxysilyl)propyl)aniline;N-(γ-(Trimethoxysilyl)propyl)aniline;TriMethoxy[3-(phenylaMino)propyl]silane;EINECS 221-328-2

Molecular Formula:C₁₂H₂₁NO₃Si

Molecular Weight:255.385

HS Code:2931900090

Physical and Chemical Properties:

Melting point:<0°C

Boiling point:309.6±25.0 °C at 760 mmHg

Density:1.0±0.1 g/cm3

Index of Refraction:1.505

PSA:39.72000

Exact Mass:255.129074

LogP:1.85

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:UN 3267 8/PG 2

Packing Group:

Contact us for information like N-[3-(Trimethoxysilyl)propyl]aniline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,EINECS 221-328-2 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-(γ-(Trimethoxysilyl)propyl)aniline Use and application,MFCD00053673 technical grade,usp/ep/jp grade.

Related News: In the first round of nationwide implement of the program, in September, multinationals including Sanofi and Eli Lilly managed to cut some prices low enough to levels close to those offered by local generic makers. N-(3-(Trimethoxysilyl)propyl)aniline manufacturer The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI). N-(3-(Trimethoxysilyl)propyl)aniline supplier FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. N-(3-(Trimethoxysilyl)propyl)aniline vendor FT819 is derived from a clonal master engineered induced pluripotent stem cell (iPSC) line with complete elimination of T-cell receptor (TCR) expression and a novel 1XX CAR targeting CD19 inserted into the T-cell receptor alpha constant (TRAC) locus. N-(3-(Trimethoxysilyl)propyl)aniline factory The glucagon-only configuration may be helpful in rare conditions that often lead to chronic, low blood-sugar conditions, such as congenital hyperinsulinism (CHI).